APA (7th ed.) Citation

X, J., WZ, L., YH, G., G, W., WY, H., & F, C. (2025). Correction: Predicting progression-free survival using dynamic contrast-enhanced imaging-based radiomics in advanced nasopharyngeal carcinoma patients treated with nimotuzumab. European radiology, 35(10), 6622. https://doi.org/10.1007/s00330-025-11530-3

Chicago Style (17th ed.) Citation

X, Jin, Li WZ, Guo YH, Wu G, Huang WY, and Chen F. "Correction: Predicting Progression-free Survival Using Dynamic Contrast-enhanced Imaging-based Radiomics in Advanced Nasopharyngeal Carcinoma Patients Treated with Nimotuzumab." European Radiology 35, no. 10 (2025): 6622. https://doi.org/10.1007/s00330-025-11530-3.

MLA (9th ed.) Citation

X, Jin, et al. "Correction: Predicting Progression-free Survival Using Dynamic Contrast-enhanced Imaging-based Radiomics in Advanced Nasopharyngeal Carcinoma Patients Treated with Nimotuzumab." European Radiology, vol. 35, no. 10, 2025, p. 6622, https://doi.org/10.1007/s00330-025-11530-3.